ClinicalTrials.Veeva

Menu

S9925: Collecting and Storing Samples From Patients With Lung Cancer

SWOG Cancer Research Network logo

SWOG Cancer Research Network

Status

Completed

Conditions

Lung Cancer

Treatments

Other: biologic sample preservation procedure

Study type

Observational

Funder types

NETWORK
NIH

Identifiers

NCT00920010
S9925 (Other Identifier)
CDR0000078624
U10CA032102 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

RATIONALE: Collecting and storing samples of tissue, blood, and sputum from patients with cancer to study in the laboratory may help the study of cancer in the future.

PURPOSE: The purpose of this study is to collect and store tissue, blood, and sputum samples from patients with lung cancer to be tested in the laboratory.

Full description

OBJECTIVES:

  • Establish a central lung cancer specimen repository to serve as a resource for current and future scientific studies.
  • Correlate clinicopathologic information in the Southwest Oncology Group clinical data base with results of studies using the repository.
  • Test new hypotheses with the specimens in the repository.

OUTLINE: Peripheral blood, sputum, and biopsy specimens are collected from patients. Tissue samples are frozen and stored in a lung cancer specimen repository for later use in correlative studies.

PROJECTED ACCRUAL: Not specified

Enrollment

2,264 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

DISEASE CHARACTERISTICS:

  • Enrolled on one of the following Southwest Oncology Group protocols:

    • SWOG-8805, SWOG-9019, SWOG-9416, SWOG-9509, SWOG-S9900, SWOG-S0003, SWOG-S0023, SWOG-S0126, SWOG-S0435, SWOG-S0220, SWOG-S0222, SWOG-S0327, SWOG-S0310, SWOG-S0339, SWOG-S0342, SWOG-S0341, SWOG-S0509, SWOG-S0429, or SWOG-S0124

PATIENT CHARACTERISTICS: Not specified

PRIOR CONCURRENT THERAPY: Not specified

Trial contacts and locations

431

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems